| 000 | 01742 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513211704.0 | ||
| 264 | 0 | _c20000905 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHarenberg, J | |
| 245 | 0 | 0 |
_aFixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cMay 2000 |
||
| 300 |
_a652-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 |
_aHeparin _xadministration & dosage |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhlebography |
| 650 | 0 | 4 | _aPopliteal Vein |
| 650 | 0 | 4 |
_aPostoperative Complications _xdiagnostic imaging |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVenous Thrombosis _xdiagnostic imaging |
| 650 | 0 | 4 |
_aVitamin K _xantagonists & inhibitors |
| 700 | 1 | _aSchmidt, J A | |
| 700 | 1 | _aKoppenhagen, K | |
| 700 | 1 | _aTolle, A | |
| 700 | 1 | _aHuisman, M V | |
| 700 | 1 | _aBüller, H R | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 83 _gno. 5 _gp. 652-6 |
|
| 999 |
_c10774852 _d10774852 |
||